To define whether this observation related to the ER status of HER2 heterogeneous breast cancers would be generalizable, we investigated the ER status of the HER2 heterogeneous breast cancers that were retrieved for this study but not amenable to microdissection. This evidence concerns the gene ESR1 and breast cancer.